Not logged in Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel Lara, Primo N.; Mayerson, Edward; Gertz, Erik; Tangen, Catherine; Goldkorn, Amir; van Loan, Marta; Hussain, Maha; Gupta, Shilpa; Zhang, Jingsong; Parikh, Mamta; Twardowski, Przemyslaw; Quinn, David I.; Leblanc, Michael; Vogelzang, Nicholas J.; Thompson, Ian; Agarwal, Neeraj Share Save
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC) Autio, Karen A.; Higano, Celestia S.; Nordquist, Luke; Appleman, Leonard J.; Zhang, Tian; Zhu, Xin-Hua; Babiker, Hani; Vogelzang, Nicholas J.; Prasad, Sandip M.; Schweizer, Michael T.; Madan, Ravi A.; Billotte, Stephane; Cavazos, Nora; Bogg, Orlaith; Li, Ray; Chan, Kam; Cho, Helen; Kaneda, Megan; Wang, I-Ming; Zheng, Jenny; Tang, Szu-Yu; Hollingsworth, Robert; Kern, Kenneth A.; Petrylak, Daniel P. Share Save
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up Balar, A. V.; Castellano, D. E.; Grivas, P.; Vaughn, D. J.; Powles, T.; Vuky, J.; Fradet, Y.; Lee, J. -L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Necchi, A.; Petrylak, D. P.; Plimack, E. R.; Xu, J. Z.; Imai, K.; Moreno, B. H.; Bellmunt, J.; de Wit, R.; O'Donnell, P. H. Share Save
Share Save
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib Loehr, Andrea; Hussain, Arif; Patnaik, Akash; Bryce, Alan H.; Castellano, Daniel; Font, Albert; Shapiro, Jeremy; Zhang, Jingsong; Sautois, Brieuc; Vogelzang, Nicholas J.; Chatta, Gurkamal; Courtney, Kevin; Harzstark, Andrea; Ricci, Francesco; Despain, Darrin; Watkins, Simon; King, Charmin; Nguyen, Minh; Simmons, Andrew D.; Chowdhury, Simon; Abida, Wassim Share Save
Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study De Wit, R.; Vaughn, D. J.; Fradet, Y.; Fong, L.; Vogelzang, N. J.; Climent Duran, M. A.; Necchi, A.; Petrylak, D. P.; Gerritsen, W. R.; Gurney, H. P.; Quinn, D. I.; Culine, S.; Sternberg, C. N.; Bajorin, D. F.; Choueiri, T. K.; Xu, J.; Imai, K.; Moreno, B. Homet; Bellmunt, J.; Lee, J-L. Share Save
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma Shohdy, Kyrillus S.; Villamar, Dario M.; Cao, Yen; Trieu, Janson; Price, Kristin S.; Nagy, Rebecca; Tagawa, Scott T.; Molina, Ana M.; Sternberg, Cora N.; Nanus, David M.; Mosquera, Juan Miguel; Elemento, Olivier; Sonpavde, Guru P.; Grivas, Petros; Vogelzang, Nicholas J.; Faltas, Bishoy Morris Share Save
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study Loehr, Andrea; Patnaik, Akash; Campbell, David; Shapiro, Jeremy; Bryce, Alan H.; McDermott, Ray; Sautois, Brieuc; Vogelzang, Nicholas J.; Bambury, Richard M.; Voog, Eric; Zhang, Jingsong; Piulats, Josep M.; Hussain, Arif; Ryan, Charles J.; Merseburger, Axel S.; Daugaard, Gedske; Heidenreich, Axel; Fizazi, Karim; Higano, Celestia S.; Krieger, Laurence E.; Sternberg, Cora N.; Watkins, Simon P.; Despain, Darrin; Simmons, Andrew D.; Dowson, Melanie; Golsorkhi, Tony; Chowdhury, Simon; Abida, Wassim Share Save
A PHASE 1B/2 RANDOMIZED STUDY OF AVB-S6-500 IN COMBINATION WITH CABOZANTINIB VERSUS CABOZANTINIB ALONE IN PATIENTS WITH ADVANCED CLEAR CELL RENAL CELL CARCINOMA WHO HAVE RECEIVED FRONT-LINE TREATMENT Beckermann, Kathryn; Vogelzang, Nicholas; Shifeng, Mao; Ornstein, Moshe; Shah, Neil; Hammers, Hans; Campbell, Matthew; Gao, Xin; McDermott, David; Anderson, Randy; Esquibel, Vanessa; Pennella, Eduardo; Rangwala, Reshma; Jonasch, Eric Share Save
Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC) Sadeghi, S.; Quinn, D. I.; Dorff, T.; Pal, S. K.; Groshen, S.; Tsao-Wei, D.; Lara, P. N.; Parikh, R.; Devitt, M. E.; Parikh, M.; Jackovich, A.; Vogelzang, N. J.; Burgess, E. F.; Dreicer, R.; Siddiqi, I.; Gill, I.; Gill, P. Share Save
Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer Fizazi, K.; Herrmann, K.; Krause, B. J.; Rahbar, K.; Chi, K. N.; Morris, M. J.; Sartor, O.; Tagawa, S. T.; Kendi, A. T.; Vogelzang, N. J.; Calais, J.; Nagarajah, J.; Wei, X. X.; Koshkin, V. S.; Beauregard, J-M.; Chang, B.; DeSilvio, M.; Messmann, R. A.; de Bono, J. Share Save
Share Save
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial van der Heijden, Michiel S.; Loriot, Yohann; Duran, Ignacio; Ravaud, Alain; Retz, Margitta; Vogelzang, Nicholas J.; Nelson, Betty; Wang, Jingjing; Shen, Xiaodong; Powles, Thomas Share Save
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; Necchi, A.; Rodriguez-Vida, A.; Gupta, S.; Josephs, D. H.; Srinivas, S.; Wride, K.; Thomas, D.; Simmons, A.; Loehr, A.; Dusek, R. L.; Nepert, D.; Chowdhury, S. Share Save
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial Bryce, Alan H.; Chen, Yu Hui; Liu, Glenn; Carducci, Michael A.; Jarrard, David M.; Garcia, Jorge A.; Dreicer, Robert; Hussain, Maha; Eisenberger, Mario Alfredo; Plimack, Elizabeth R.; Vogelzang, Nicholas J.; DiPaola, Robert S.; Harshman, Lauren; Sweeney, Christopher J. Share Save
Association between gene expression signatures (sigs) and pembrolizumab (pembro) efficacy in patients (pts) with advanced urothelial cancer (UC) Grivas, P.; Balar, A. V.; Vuky, J.; de Wit, R.; Vogelzang, N. J.; Choueiri, T. K.; Bajorin, D.; Castellano Gauna, D.; Gerritsen, W.; Gurney, H.; Quinn, D. I.; Culine, S.; Fradet, Y.; Saadatpour, A.; Loboda, A.; Ma, J.; Rajasagi, M.; Godwin, J. L.; Moreno, B. H.; Bellmunt, J. Share Save
Rucaparib population pharmacokinetics (PPK) and exposure-response (ER) analyses in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in TRITON2 Chowdhury, S.; Patnaik, A.; Campbell, D.; Shapiro, J.; Bryce, A. H.; McDermott, R.; Sautois, B.; Vogelzang, N. J.; Bambury, R.; Voog, E.; Zhang, J.; Green, M.; Beltman, J.; Despain, D.; Simmons, A. D.; Watkins, S. P.; Golsorkhi, A.; Xiao, J.; Abida, W. Share Save
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study Abida, Wassim; Campbell, David; Patnaik, Akash; Shapiro, Jeremy D.; Sautois, Brieuc; Vogelzang, Nicholas J.; Voog, Eric G.; Bryce, Alan H.; McDermott, Ray; Ricci, Francesco; Rowe, Julie; Zhang, Jingsong; Piulats, Josep Maria; Fizazi, Karim; Merseburger, Axel S.; Higano, Celestia S.; Krieger, Laurence E.; Ryan, Charles J.; Feng, Felix Y.; Simmons, Andrew D.; Loehr, Andrea; Despain, Darrin; Dowson, Melanie; Green, Foad; Watkins, Simon P.; Golsorkhi, Tony; Chowdhury, Simon Share Save
Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)-final PROCEED analysis Sartor, Oliver; Armstrong, Andrew J.; Ahaghotu, Chiledum; McLeod, David G.; Cooperberg, Matthew R.; Penson, David F.; Kantoff, Philip W.; Vogelzang, Nicholas J.; Hussain, Arif; Pieczonka, Christopher M.; Shore, Neal D.; Quinn, David, I; Heath, Elisabeth, I; Tutrone, Ronald F.; Schellhammer, Paul F.; Harmon, Matthew; Chang, Nancy N.; Freedland, Stephen J.; Higano, Celestia S. Share Save
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial Galsky, Matthew D.; Arranz Arija, Jose Angel; Bamias, Aristotelis; Davis, Ian D.; De Santis, Maria; Kikuchi, Eiji; Garcia-del-Muro, Xavier; De Giorgi, Ugo; Mencinger, Marina; Izumi, Kouji; Panni, Stefano; Gumus, Mahmut; Ozguroglu, Mustafa; Kalebasty, Arash Rezazadeh; Park, Se Hoon; Alekseev, Boris; Schutz, Fabio A.; Li, Jian-Ri; Ye, Dingwei; Vogelzang, Nicholas J.; Bernhard, Sandrine; Tayama, Darren; Mariathasan, Sanjeev; Mecke, Almut; Thastrom, AnnChristine; Grande, Enrique Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
Share.png){kind=icon}
Save